Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 488,314
  • Shares Outstanding, K 39,222
  • Annual Sales, $ 41,020 K
  • Annual Income, $ 2,920 K
  • EBIT $ 3 M
  • EBITDA $ 5 M
  • 60-Month Beta 1.20
  • Price/Sales 10.50
  • Price/Cash Flow 92.96
  • Price/Book 6.29

Options Overview Details

View History
  • Implied Volatility 220.29% (-56.17%)
  • Historical Volatility 63.51%
  • IV Percentile 97%
  • IV Rank 69.73%
  • IV High 295.65% on 11/20/25
  • IV Low 46.66% on 01/16/26
  • Expected Move (DTE 15) 0.00 (0.00%)
  • Put/Call Vol Ratio 14.00
  • Today's Volume 15
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 478
  • Open Int (30-Day) 319
  • Expected Range 12.84 to 12.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 2
  • High Estimate 0.07
  • Low Estimate 0.04
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.48 +22.66%
on 02/06/26
13.31 -3.45%
on 02/18/26
+2.39 (+22.84%)
since 02/05/26
3-Month
7.99 +60.99%
on 12/17/25
13.31 -3.45%
on 02/18/26
+4.22 (+48.87%)
since 12/05/25
52-Week
3.92 +227.93%
on 04/21/25
13.31 -3.45%
on 02/18/26
+8.00 (+165.05%)
since 03/05/25

Most Recent Stories

More News
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion

EQNX::TICKER_START (NNASDAQ:HELP),(CBOE:HELP),(NASDAQ:ACHC),(NYSE:JNJ),(NASDAQ:BWAY),(NASDAQ:AIFF) EQNX::TICKER_END

HELP : 5.40 (-36.69%)
BWAY : 12.85 (+3.21%)
ACHC : 24.54 (+1.95%)
AIFF : 1.3400 (-13.55%)
JNJ : 236.47 (-3.60%)
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial...

BWAY : 12.85 (+3.21%)
HYFT : 1.1700 (-0.85%)
ICAD : 3.87 (+3.75%)
BrainsWay Announces Cashless Exercise of Warrant by Valor

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Brainsway...

BWAY : 12.85 (+3.21%)
Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay

CORAL SPRINGS, Fla. and NETANYA, Israel , Aug. 21, 2025 /PRNewswire/ -- Neurolief, a pioneering brain stimulation company specializing in non-invasive neuromodulation therapies,...

BWAY : 12.85 (+3.21%)
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns

Net profit, also referred to as the bottom line, is one of the key tools to determine the financial health of an enterprise. The metric demonstrates a company’s ability to convert per-dollar sales into...

BWAY : 12.85 (+3.21%)
ORN : 12.06 (-10.00%)
CPRX : 24.34 (-1.42%)
GAMB : 4.47 (+3.47%)
Is the Options Market Predicting a Spike in Brainsway Stock?

Investors in Brainsway Ltd. BWAY need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $12.50 Call had some of the highest implied volatility...

BWAY : 12.85 (+3.21%)
Zacks.com featured highlights include SB Financial Group, First Community, StoneX Group, Byrna Technologies and BrainsWay

For Immediate ReleaseChicago, IL – February 14, 2025 – Stocks in this week’s article are — SB Financial Group Inc. SBFG, First Community Corp. FCCO, StoneX Group Inc. SNEX, Byrna Technologies Inc....

BWAY : 12.85 (+3.21%)
SBFG : 20.51 (-0.63%)
SNEX : 120.33 (-2.47%)
FCCO : 28.47 (-1.49%)
BYRN : 12.42 (-2.36%)
5 Stocks With Recent Price Strength to Enhance Your Portfolio

U.S. stock markets witnessed an impressive rally in 2024 after an astonishing bull run in 2023. Despite fluctuations, the bull run continued in 2025. Market participants remained concerned about the Trump...

BWAY : 12.85 (+3.21%)
SBFG : 20.51 (-0.63%)
SNEX : 120.33 (-2.47%)
FCCO : 28.47 (-1.49%)
BYRN : 12.42 (-2.36%)
Zacks.com featured highlights include Bridgewater Bancshares, Eastern Bankshares and BrainsWay

For Immediate ReleaseChicago, IL – February 7, 2025 – Stocks in this week’s article are — Bridgewater Bancshares, Inc. BWB, Eastern Bankshares, Inc. EBC and BrainsWay Ltd. BWAY.3 Top-Ranked Breakout...

BWAY : 12.85 (+3.21%)
EBC : 19.21 (-1.74%)
BWB : 17.80 (-3.63%)
Zacks.com featured highlights include Mission Produce, Accel Entertainment, BrainsWay and First Bank

For Immediate ReleaseChicago, IL – February 7, 2025 – Stocks in this week’s article are — Mission Produce, Inc. AVO, Accel Entertainment Inc. ACEL, BrainsWay, Ltd. BWAY and First Bank FRBA.4 Top-Ranked...

BWAY : 12.85 (+3.21%)
ACEL : 12.28 (-5.97%)
FRBA : 15.76 (-2.66%)
AVO : 13.75 (-3.85%)

Business Summary

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder....

See More

Key Turning Points

3rd Resistance Point 13.73
2nd Resistance Point 13.20
1st Resistance Point 12.82
Last Price 12.85
1st Support Level 11.92
2nd Support Level 11.39
3rd Support Level 11.02

See More

52-Week High 13.31
Last Price 12.85
Fibonacci 61.8% 9.73
Fibonacci 50% 8.62
Fibonacci 38.2% 7.51
52-Week Low 3.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar